Intrauterine [bsoj]
Administration, Oral [topp]
Levonorgestrel [horm, phsu, strd]
Combination [qlco]
Estradiol [horm, phsu, strd]
Perimenopausal [tmco]
Women [popg]
effects [qlco]
Lipid Metabolism [moft]
months [tmco]
treatment [ftcn]
Objective [inpr]
Limited [ftcn]
Concern [idcn]
Serum lipids NOS [lbpr]
Lipoproteins [aapp, bacs]
Available [ftcn]
HRT [topp]
Perimenopausal [tmco]
Women [popg]
Marked [qlco]
Bleeding [patf]
Disturbance [qlco]
severe symptoms [fndg]
Climacteric [orgf]
Published [ocac]
Form [qlco]
Lipoprotein [aapp, bacs]
Includes [ftcn]
estimation [menp]
determination [lbpr]
Cholesterol, LDL [bacs, strd]
Locally [spco]
Administered [ftcn]
Progestagen [horm, phsu, strd]
Perimenopausal [tmco]
Women [popg]
Study [mnob]
Patients [podg]
Methods [inpr]
Perimenopausal [tmco]
Women [popg]
Climacteric [orgf]
complaints [fndg]
Continuous [idcn]
Release [hlca]
Low dose [qnco]
Levonorgestrel [horm, phsu, strd]
Intra Uterine Device [medd]
Progestagen [horm, phsu, strd]
Medication [phsu]
Estradiol [horm, phsu, strd]
New type [idcn]
Continuous [idcn]
Combined [qlco]
Hormone replacement therapy [topp]
Women [popg]
randomized [resa]
Cyclical [tmco]
treatment [ftcn]
mg% [qnco]
Oral [spco]
Oestradiol valerate [horm, phsu, strd]
Combination [qlco]
mU/g [qnco]
Levonorgestrel [horm, phsu, strd]
Last [qlco]
TEN-DAY [inpr]
cyclo-progynova [horm, phsu, strd]
mg% [qnco]
Oestradiol valerate [horm, phsu, strd]
Orally [spco]
Combination [qlco]
mU/g [qnco]
Hour [tmco]
Levonorgestrel [horm, phsu, strd]
Releasing [ftcn]
Intra Uterine Device [medd]
Reduced [qlco]
Cholesterol, HDL [bacs, lipd]
Initially [tmco]
Record [inpr]
Treatment Arm [resa]
Altered [ftcn]
treatment [ftcn]
Triglycerides [bacs, lipd]
Reduced [qlco]
Orally [spco]
treated [topp]
Group [idcn]
Device [medd]
Group [idcn]
Cholesterol, LDL [bacs, strd]
Note [clna]
Conclusions [idcn]
findings [ftcn]
Suggest [idcn]
Continuous [idcn]
Combined [qlco]
HRT [topp]
Intrauterine [bsoj]
Release [hlca]
mU/g [qnco]
Levonorgestrel [horm, phsu, strd]
24 hours [tmco]
Perimenopausal [tmco]
Women [popg]
Neutral [qlco]
Lipid Metabolism [moft]
Concern [idcn]
Alteration [idcn]
Compared [acty]
Pretreatment [sbst]
Values [qlco]
Note [clna]
months [tmco]
treatment [ftcn]
Marked [qlco]
Lipid [lipd]
Obtained [ftcn]
Perimenopausal [tmco]
Women [popg]
Compared [acty]
postmenopausal [tmco]
Women [popg]
methodology [inpr]
account [idcn]
